The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of inactivation of STK11/ LKB1 with a suppressive immune microenvironment in lung adenocarcinoma (LUAC).
 
Ferdinandos Skoulidis
No Relationships to Disclose
 
Warren Denning
No Relationships to Disclose
 
Lixia Diao
No Relationships to Disclose
 
Pan Tong
No Relationships to Disclose
 
You Hong Fan
No Relationships to Disclose
 
Vassiliki Papadimitrakopoulou
Consulting or Advisory Role - Amgen/Dompé; Clovis Oncology; Janssen Oncology
Research Funding - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Merck Sharp & Dohme; Novartis
 
Julie Izzo
No Relationships to Disclose
 
Carmen Behrens
No Relationships to Disclose
 
Humam Kadara
No Relationships to Disclose
 
Edwin Roger Parra Cuentas
No Relationships to Disclose
 
Jaime Rodriguez
No Relationships to Disclose
 
Jing Wang
No Relationships to Disclose
 
Don Lynn Gibbons
No Relationships to Disclose
 
Lauren Averett Byers
No Relationships to Disclose
 
Ignacio Ivan Wistuba
Consulting or Advisory Role - GE Healthcare; Genecentric; Genentech/Roche; GlaxoSmithKline; Lilly
Speakers' Bureau - Boehringer Ingelheim; Pfizer
Research Funding - Bayer; Genentech; Merck; Myriad Genetics; OncoPlex Diagnostics
 
John Heymach
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Genentech; GlaxoSmithKline; Pfizer
Research Funding - AstraZeneca